- Report
- December 2023
- 80 Pages
China
From €1391EUR$1,500USD£1,163GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1391EUR$1,500USD£1,163GBP
From €1391EUR$1,500USD£1,163GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$4,044USD£3,030GBP
- Report
- October 2025
- 95 Pages
Kuwait
From €4172EUR$4,500USD£3,490GBP
- Report
- December 2023
- 80 Pages
Russia
From €1391EUR$1,500USD£1,163GBP
- Report
- November 2023
- 90 Pages
Global
From €3500EUR$4,044USD£3,030GBP
- Report
- May 2023
- 93 Pages
Global
From €3500EUR$4,044USD£3,030GBP
- Report
- February 2022
- 90 Pages
Global
From €3200EUR$3,697USD£2,770GBP
- Report
- November 2026
- 50 Pages
Global
From €2457EUR$2,650USD£2,055GBP
From €120EUR$129USD£100GBP
Artemisinin is a drug used to treat a variety of infectious diseases, including malaria, schistosomiasis, and filariasis. It is derived from the plant Artemisia annua, and is used in combination with other drugs to increase its effectiveness. Artemisinin is a potent antimalarial drug, and is the most effective treatment for malaria. It is also used to treat other parasitic infections, such as schistosomiasis and filariasis.
Artemisinin is available in a variety of forms, including tablets, capsules, and injections. It is also available in combination with other drugs, such as mefloquine, piperaquine, and doxycycline. The drug is generally well tolerated, with few side effects.
The Artemisinin market is highly competitive, with many companies offering the drug in various forms. Some of the companies in the market include Novartis, Sanofi, GlaxoSmithKline, Cipla, and Ranbaxy. Show Less Read more
